Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement
- DOI
- 10.1007/s00277-026-06953-x
- Published
- 2026-04-10
- Container
- Annals of Hematology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-026-06953-x,
title = {Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement},
author = {Marco Frigeni and Alessandra Algarotti and Silvia Salmoiraghi and Clara Belotti and Martina Milani and Chiara Pavoni and Orietta Spinelli and Irene Gotuzzo and Alessandro Rambaldi and Federico Lussana},
year = {2026},
journal = {Annals of Hematology},
doi = {10.1007/s00277-026-06953-x},
url = {https://doi.org/10.1007/s00277-026-06953-x}
}RIS
TY - JOUR TI - Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement AU - Marco Frigeni AU - Alessandra Algarotti AU - Silvia Salmoiraghi AU - Clara Belotti AU - Martina Milani AU - Chiara Pavoni AU - Orietta Spinelli AU - Irene Gotuzzo AU - Alessandro Rambaldi AU - Federico Lussana PY - 2026 JO - Annals of Hematology DO - 10.1007/s00277-026-06953-x UR - https://doi.org/10.1007/s00277-026-06953-x ER -
APA
Frigeni, M., Algarotti, A., Salmoiraghi, S., Belotti, C., Milani, M., Pavoni, C., Spinelli, O., Gotuzzo, I., Rambaldi, A., & Lussana, F. (2026). Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement. Annals of Hematology. https://doi.org/10.1007/s00277-026-06953-x
Source records
- crossref · retrieved 2026-11-08T03:55:22.433Z